Making the Case for Dual Ang-2 VEGF-A Inhibition: Durability and Drying
MP3•Jakson koti
Manage episode 414417313 series 3381434
Sisällön tarjoaa ReachMD. ReachMD tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.
CME credits: 0.25
Valid until: 15-04-2025
Claim your CME credit at https://reachmd.com/programs/cme/making-the-case-for-dual-ang-2-vegf-a-inhibition-durability-and-drying/18008/
What are the biomarkers that indicate dual targeting helps to reduce vascular leakage and suppress neovascularization? Join Dr. Carl Regillo and Dr. Jennifer Lim as they discuss the biomarkers of Ang-2 and VEGF-A suppression. Hear how to achieve earlier and faster fluid resolution in both neovascular age-related macular degeneration and diabetic macular edema.=
…
continue reading
Valid until: 15-04-2025
Claim your CME credit at https://reachmd.com/programs/cme/making-the-case-for-dual-ang-2-vegf-a-inhibition-durability-and-drying/18008/
What are the biomarkers that indicate dual targeting helps to reduce vascular leakage and suppress neovascularization? Join Dr. Carl Regillo and Dr. Jennifer Lim as they discuss the biomarkers of Ang-2 and VEGF-A suppression. Hear how to achieve earlier and faster fluid resolution in both neovascular age-related macular degeneration and diabetic macular edema.=
598 jaksoa